[Polysaccharide vaccines. II. Meningococcal vaccines].
A short history of vaccination and troubles connected with preparation of vaccine effective in preventing serogroup B meningococcal diseases was described. Different kinds of meningococcal vaccines used all over the world and epidemiological situation in Poland was also discussed.
T, Wysokińska, W, Janaszek
openaire +1 more source
Meningococcal polysaccharide–protein conjugate vaccines
It is now 5 years since the UK became the first country to introduce the serogroup C meningococcal polysaccharide-protein conjugate vaccines (MenC) into its routine immunisation schedule. This article reviews the global use of MenC with particular reference to the range of immunisation strategies used internationally.
Snape, MD, Pollard, A
openaire +2 more sources
PEARL: Protein Eluting Alginate with Recombinant Lactobacilli
Probiotic lactobacilli meet engineered living materials: This study introduces PEARL (protein eluting alginate with recombinant lactobacilli), an innovative engineered living material combining Lactiplantibacillus plantarum and alginate beads for controlled protein release.
Varun Sai Tadimarri +7 more
wiley +1 more source
Novel Wide‐Spectrum Virucidal Lipid Nanoparticles
POSTAN is a novel broad‐spectrum antiviral nanoparticle that combines safety with potent virucidal activity. Composed of biocompatible lipids, it mimics heparan sulfate proteoglycans and lipid rafts exploited by viruses, thereby dismantling viral envelopes and blocking replication.
Yugo Araújo Martins +10 more
wiley +1 more source
Increased Invasive Pneumococcal Disease, North East England, UK
Since April 2014, invasive pneumococcal disease incidence has increased substantially across North East England, United Kingdom, reversing the decline that followed the 2006 introduction of pneumococcal conjugate vaccines.
Catherine Houseman +4 more
doaj +1 more source
Vaccinations During Pregnancy Protect the Mother–Infant Dyad and Are Generally Safe
ABSTRACT Aim Vaccination in pregnancy has a critical impact on mothers, foetuses and infants. The aim of this paper was to summarise key points presented by experts attending the 12th Maria Delivoria‐Papadopoulos Perinatal Symposium in March 2025 and further expand and update them.
Ariadne Malamitsi‐Puchner +2 more
wiley +1 more source
Nonencapsulated
While significant protection from pneumococcal disease has been achieved by the use of polysaccharide and polysaccharide-protein conjugate vaccines, capsule-independent protection has been limited by serotype replacement along with disease caused by ...
Lance E. Keller +2 more
doaj +1 more source
Infections in Chronic Lymphocytic Leukemia: Evolving Risks and Prevention Strategies
ABSTRACT Infections remain a leading cause of morbidity and mortality in patients with chronic lymphocytic leukemia (CLL), reflecting both intrinsic immune dysfunction and therapy‐related immunosuppression. The pathogenesis of immunodeficiency in CLL is multifactorial: neoplastic B cells impair humoral immunity, T cells are functionally exhausted, and ...
Enrica Antonia Martino +10 more
wiley +1 more source
Decreased Point Prevalence ofHaemophilus influenzaeType b (Hib) Oropharyngeal Colonization by Mass Immunization of Brazilian Children Less Than 5 Years Old with Hib Polyribosylribitol Phosphate Polysaccharide–Tetanus Toxoid Conjugate Vaccine in Combination with Diphtheria‐Tetanus Toxoids–Pertussis Vaccine [PDF]
Eduardo Forleo‐Neto +11 more
openalex +1 more source
Comparative Transcriptome Profiling of mRNA and lncRNA of Mouse Spleens Inoculated with the Group ACYW135 Meningococcal Polysaccharide Vaccine [PDF]
Nan Zhu +8 more
openalex +1 more source

